NCT04581928

Brief Summary

Patients reactions towards their diagnosis as having COVID-19. The effect of patients' reaction toward their prospect management. How this can make many hazards. Also, obstacle and barrier to better management.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,812

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

October 10, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

3 years

First QC Date

October 6, 2020

Last Update Submit

September 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to recovery

    Time needed to recovery from symptoms of covid-19

    Four weeks

Study Arms (1)

COVID-19

Highly educated people Low educated people

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All COVID-19 cases

You may qualify if:

  • COVID-19
  • Age 18 years of less

You may not qualify if:

  • Mental diseases making the communication with them difficult

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asalam

Maadi, Cairo Governorate, 11433, Egypt

RECRUITING

Related Publications (1)

  • Wiseman EJ. Denial in the medical interview. JAMA. 1995 Jun 14;273(22):1735; author reply 1735-6. doi: 10.1001/jama.273.22.1735. No abstract available.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Emad R Issak, MD

    Assalam Clinics

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 9, 2020

Study Start

October 10, 2020

Primary Completion

October 10, 2023

Study Completion

December 30, 2023

Last Updated

September 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Individual data will not shared as per local regulations

Locations